The TGA has approved a reduction in EpiPen and EpiPen Jr injection time by more than half – from ten to three seconds
This means that, in the emergency treatment of anaphylaxis or acute allergic reactions, the full dose of adrenaline (epinephrine) from the Auto-injector has been confirmed as effective via a three-second delivery.
Guidance to massage the site post injection has also been removed, following the review of data which showed massaging the site may cause tissue irritation.
“Given a large proportion of allergy sufferers, and even healthcare professionals, can’t demonstrate correct technique to use the EpiPen, simplification of the process is a welcome step,” says Dr Brynn Wainstein, Chair of the Anaphylaxis ommittee and President of the Australasian Society of Clinical Immunology and Allergy.
“It’s also a timely opportunity to remind these groups of the proper technique,” he says.
EpiPen and Epipen Jr Auto-Injectors with the three-second label will start to arrive in pharmacies from around June/July 2017 and will gradually replace ten-second labelled pens in the Australian market.
Patients and pharmacies with the existing stock should continue to carry these pens, however they can inform patients that they only need to be held in place for three seconds.
“This is an important opportunity for healthcare professionals, particulars GPs and pharmacists, to continue to encourage the correct use of the EpiPen, along with informing patients of this reduction in injection time, given many may still be carrying a ten-second labelled EpiPen for several months.
“The actual EpiPen and its contents have not changed at all, just the time to use it.”